Evidence map›Paper›PMID 33452767›Full record

ArticleIndian pediatrics2021

Outcome of Children Admitted With SARS-CoV-2 Infection: Experiences From a Pediatric Public Hospital.

Sudha Rao, Vrushabh Gavali, Shakuntala S Prabhu, Radhika Mathur, Larissa Robert Dabre, Sanjay B Prabhu, Minnie Bodhanwala

Open access · bronzeAbstract read
In one paragraph

Article in Indian pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sudha RaoDepartment of Pediatrics, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India. Correspondence to: Dr. Sudha Rao, Professor and, Head Department of Pediatrics, Bai Jerbai Wadia Hospital for Children, Acharya Dhonde Marg, Parel, Mumbai, India. c_sudha@hotmail.com.
Vrushabh GavaliDepartment of Pediatrics, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.
Shakuntala S PrabhuDepartment of Pediatrics, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.
Radhika MathurDepartment of Pediatrics, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.
Larissa Robert DabreDepartment of Pediatrics, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.
Sanjay B PrabhuDepartment of Pediatrics, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.
Minnie BodhanwalaDepartment of Pediatrics, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.
Bai Jerbai Wadia Hospital for Children · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study clinical characteristics and outcome of children with admitted to a paediatric hospital in Mumbai, India.

methodsReview of medical records of 969 children admitted between 19 March and 7 August, 2020, to assess the clinico-demographic characteristics, disease severity and factors predicting outcome in COVID-19 children. Variables were compared between children who were previously healthy (Group I) and those with co-morbidity (Group II).

results123 (71 boys) children with median (IQR) age of 3 (0.7- 6) years were admitted, of which 47 (38%) had co-morbidities. 39 (32 %) children required intensive care and 14 (11.4%) died. Male sex, respiratory manifestation, oxygen saturation <94%; at admission, mechanical ventilation, inotrope, hospital stay of <10 days were independent predictors of mortality. Oxygen saturation <94% at admission (OR 35.9, 95% CI 1.5-856) and hospital stay <10 days (OR 9.1, 95% CI 1.04-99.1) were significant.

conclusionCOVID-19 in children with co-morbidities causes severe disease. Association of mortality with oxygen saturation by pulse oximeter <94% on admission, and hospital stay <10 days, needs further evaluation.

Indexed as

COVID-19HypoxiaRespiration, ArtificialCardiotonic AgentsChild, PreschoolComorbidityFemaleHospitalizationHumansIndiaIntensive Care Units, PediatricMaleMortalityOutcome and Process Assessment, Health CarePrognosisSARS-CoV-2Cardiotonic Agents

Identifiers

PMID33452767
PMCPMC8079837
OpenAlexW3123296681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.